UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
June 30, 2022
Accession Number:
Submission Type:
CIK:
0001885827
Company Name:
Virax Biolabs Group Ltd
File Number:
333-263694